Research ArticleLaboratory Studies
Experimental and Clinical Analysis of the Characteristics of a Chimeric Monoclonal Antibody, MOv18, Reactive with an Ovarian Cancer-Associated Antigen
Carla F. Molthoff, Marrije R. Buist, Peter Kenemans, Herbert M. Pinedo and Epie Boven
Journal of Nuclear Medicine November 1992, 33 (11) 2000-2005;
Carla F. Molthoff
Marrije R. Buist
Peter Kenemans
Herbert M. Pinedo


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Experimental and Clinical Analysis of the Characteristics of a Chimeric Monoclonal Antibody, MOv18, Reactive with an Ovarian Cancer-Associated Antigen
Carla F. Molthoff, Marrije R. Buist, Peter Kenemans, Herbert M. Pinedo, Epie Boven
Journal of Nuclear Medicine Nov 1992, 33 (11) 2000-2005;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Antitumor Effects of a Human Dimeric Antibody Fragment 131I-AFRA-DFM5.3 in a Mouse Model for Ovarian Cancer
- Preclinical evaluation of MORAb-003, a humanized monoclonal antibody antagonizing folate receptor-alpha
- Optimal Quality 131I-Monoclonal Antibodies on High-Dose Labeling in a Large Reaction Volume and Temporarily Coating the Antibody with IODO-GEN
- A Structurally Altered Human Reduced Folate Carrier with Increased Folic Acid Transport Mediates a Novel Mechanism of Antifolate Resistance